G20
Conditions
Interventions
Group 1: BIG therapy classic (16 hrs / 4weeks)
Group 2: BIG therapy short version (10hrs/2 weeks)
Sponsors
Neurologisches Fachkrankenhaus für Bewegungsstörungen / Parkinson
Deutsche Parkinson Vereinigung e.V.
Eligibility
Sex/Gender
All
Age
30 Years to 85 Years
Inclusion criteria
Inclusion criteria: Idiopathic Parkinson Stage Hoehn & Yahr I-III · UPDRS-Motor-Score (III) 12 or more comprising at least 6 points on bradykinesia-items. Ambulatory without walking-aids. Willingness to participate in a randomized study. Sufficient time and mobility for intensive out-patient-treatment
Exclusion criteria
Exclusion criteria: · Dementia(MMSE < 20) · Severe Depression · Severe Dyskinesia when ON · Motor impairment due zto other diseases · Reduced abilizty to practice due to cardiac or other diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| UPDRS-Motor-Score (Sum score of all itemns of UPDRS Part III) in ON-state (Rater blinded video-rating) at baseline, 4 weeks, 8 weeks and 16 weeks. UODRS part III is the international standard for the assessment of motor performance in PD. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life (PDQ-39), ADL (UPDRS Part II), cognitive function (TAP) Motivation (Paremo-20) Gait analysis (Hasomed) and timed-tests (6-min-walk-Test, stand-walk-sit-Test, Box & Block-Test) will be assessed at baseline and at 16 weeks follow-up. Walking velocity will be measured by manual stopwatch on a 20m indoor parcours. The stand-walk-sit test comprises raising from a chair- walking 5m-turn-walking back 5m-sit down. | — |
Countries
Germany
Contacts
Public ContactGeorg Ebersbach
Outcome results
None listed